nifedipine has been researched along with Cancer of Kidney in 2 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arana Aguirre, N | 1 |
| Montiano Jorge, JI | 1 |
| Navajas Gutiérrez, A | 1 |
| Vallo Boado, A | 1 |
| San Román Salcines, C | 1 |
| Guiu Solano, MA | 1 |
| Schwartsmann, G | 1 |
| Medina de Cunha, F | 1 |
| Silveira, LA | 1 |
| Salgado, G | 1 |
| Thereza, MS | 1 |
| Vinholes, J | 1 |
| Preger, P | 1 |
| Segal, F | 1 |
2 other studies available for nifedipine and Cancer of Kidney
| Article | Year |
|---|---|
[Renal insufficiency due to captopril in one patient with Burkitt's lymphoma].
Topics: Burkitt Lymphoma; Captopril; Child; Humans; Hypertension; Kidney; Kidney Neoplasms; Male; Neoplasm S | 1993 |
Phase II trial of vinblastine plus nifedipine (VN) in patients with advanced renal cell carcinoma (RCC). Brazilian Oncology Trials Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Evaluation; Drug Resista | 1991 |